<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000766992"><TermName>XELIRI regimen</TermName><TermPronunciation>(... REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used to treat colorectal cancer that has spread to other parts of the body. It is also used to treat esophageal cancer and stomach cancer that are advanced or have spread to other parts of the body. It includes the drugs capecitabine (Xeloda) and irinotecan hydrochloride. Also called CAPIRI, CAPIRI regimen,  and XELIRI.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000769343" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;XELIRI regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000769342" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen de XELIRI&quot;" language="es" id="_4"/><SpanishTermName>régimen de XELIRI</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura de una quimioterapia combinada que se usa para tratar el cáncer colorrectal que se diseminó a otras partes del cuerpo.  También se usa para tratar el cáncer de esófago y de estómago avanzados o que se diseminaron a otras partes del cuerpo.  Incluye los medicamentos capecitabina (Xeloda) y clorhidrato de irinotecán.  También se llama CAPIRI, régimen de CAPIRI,  y XELIRI.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2014-12-08</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef href="CDR0000767018">XELIRI</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
